Loading stock data…
cbdMD, Inc. (YCBD)
$0.50+0.02 (+5.07%)
Market ClosedLast close Sep 8
cbdMD, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
cbdMD, Inc. in the Healthcare sector is trading at $0.50 with a market capitalization of $7M. The stock is currently near its 52-week low of $0.45, remaining 35.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.64M↑ | $5.02M↑ | $4.72M↑ | $4.61M↓ | $4.75M |
| Gross Profit | $3.26M↑ | $3.00M↑ | $2.78M↓ | $2.83M↓ | $2.96M |
| Operating Income | -$800,784↓ | -$286,288↑ | -$685,816↑ | -$904,686↓ | -$485,816 |
| Net Income | -$797,978↓ | -$283,131↑ | -$679,968↑ | -$895,272↓ | -$480,757 |
Peer Comparison
JNJUNHPFE
Fundamentals
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.35M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.28
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.61%
Volume
Today's trading volume
34,318
Recent News
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ...
cbdMD Inc (YCBD) reports 20% revenue growth driven by wholesale and Oasis brand momentum, while implementing aggressive cost reductions to lower breakeven and navigate a shifting regulatory landscape.
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results
cbdMD Inc (NYSEAMERICAN:YCBD) is one of the best CBD stocks to buy right now. The stock has gained around 35% over the past six months, and analysts see more upside potential, expecting the stock to surge more than 160% over the next 12 months. cbdMD Inc (NYSEAMERICAN:YCBD) reported its March quarter results on May 14. […]
cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges
cbdMD Inc (YCBD) reports a 19% increase in net sales and strategic investments, while navigating cost pressures and regulatory hurdles.
cbdMD, Inc. Q3 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q3 2026 earnings call
cbdMD, Inc. Q2 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q2 2026 earnings call